Michael Torres focuses on innovation at the intersection of technology, medicine, and healthcare delivery. His coverage spans medical devices, digital health, diagnostics, and emerging care models. At BioIntel, Michael evaluates how new tools translate from concept to real-world impact, considering clinical evidence, adoption challenges, and broader industry implications.